Using proteomics to discover novel biomarkers for fatty liver development and response to CB1R antagonist treatment in an obese mouse model-Reference-Cited by-同舟云学术

Using proteomics to discover novel biomarkers for fatty liver development and response to CB1R antagonist treatment in an obese mouse model

Author:

Chen Chin-Chang¹²,Lee Tzung-Yan²,Kwok Ching-Fai³,Hsu Yung-Pei⁴,Shih Kuang-Chung⁵,Lin Yan-Jie⁶,Ho Low-Tone¹³⁴⁷

Affiliation:

1. Institute of Physiology; National Yang-Ming University; Taipei Taiwan

2. Graduate Institute of Traditional Chinese Medicine; Chang Gung University; Taoyuan Taiwan

3. Division of Endocrinology and Metabolism; Department of Medicine; Taipei Veterans General Hospital; Taipei Taiwan

4. Department of Medical Research; Taipei Veterans General Hospital; Taipei Taiwan

5. Department of Medicine-Metabolism; Cheng Hsin General Hospital; Taipei Taiwan

6. Department of Research Planning and Development; National Health Research Institutes; Miaoli Taiwan

7. School of Medicine; National Yang-Ming University; Taipei Taiwan

Funder

Internal projects of Taipei Veterans General Hospital

Ministry of Science and Technology, Taiwan

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Reference56 articles.

1. New genes involved in hepatic steatosis;Lou-Bonafonte;Curr. Opin. Lipidol.,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献